In this post, as well as many others written by my colleagues (and linked to below), you will find the topbuys and sells of 20 fund managers, analysts and hedge fund pros.
Generic drugmaker Able Labs (nasdaq: ABRX - news - people ) is also high on Oberweis' list of topbuys, along with chemical and pharmaceutical firm Aceto (nasdaq: ACET - news - people ) as well as medical testing company Biosite (nasdaq: BSTE - news - people ).